News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Karyopharm Therapeutics (KPTI) Announces Proposed Public Offering Of Common Stock



6/26/2014 7:40:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NATICK, Mass., June 25, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced that it has commenced an underwritten public offering of 2,200,000 shares of its common stock. The offering is expected to consist of 2,000,000 shares to be offered by Karyopharm and 200,000 shares to be offered by existing stockholders. Karyopharm will not receive any proceeds from the sale of shares by the selling stockholders. In addition, Karyopharm intends to grant the underwriters a 30-day option to purchase up to an additional 330,000 shares of common stock.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES